These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2961830)

  • 21. [The clinical usefulness of serum SCC antigen level determinations in patients with malignant tumor].
    Mitsuhashi N; Nagai T; Okazaki A; Hayakawa K; Katoh S; Sugiyama S; Nakayama Y; Niibe H
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2182-90. PubMed ID: 3446738
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP].
    Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2107-13. PubMed ID: 2456039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
    Chen C; Chen LQ; Chen LD; Yang GL; Li Y
    Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Limitation of clinical usefulness of tumor marker].
    Ishii M
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1139-45. PubMed ID: 7544963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer?
    Gullo L; Pezzilli R; Ventrucci M; Lesi C; Zoni L; D'Ambrosi A; Alvisi V
    Pancreas; 1989; 4(3):335-8. PubMed ID: 2734276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.
    Coleman RE; Major P; Lipton A; Brown JE; Lee KA; Smith M; Saad F; Zheng M; Hei YJ; Seaman J; Cook R
    J Clin Oncol; 2005 Aug; 23(22):4925-35. PubMed ID: 15983391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC.
    Ross A; Sardi A; Nieroda C; Merriman B; Gushchin V
    Eur J Surg Oncol; 2010 Aug; 36(8):772-6. PubMed ID: 20561764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
    Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An investigation of extracellular HER-2/NEU domain level in blood serum from breast cancer patients].
    Korytova LI; Masliukova EA; Ovchinnikov IV; Filipenko MO; Korytov OV; Kudaĭbergenova AG
    Vopr Onkol; 2010; 56(1):62-5. PubMed ID: 20361618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic value of hematopoietic cytokines measurement in the sera of gastric cancer and gastric ulcer patients.
    Mroczko B; Wereszczyñska-Siemiatkowska U; Groblewska M; Lukaszewicz M; Szmitkowski M; Gryko M; Kedra B
    Clin Chim Acta; 2006 Dec; 374(1-2):165-7. PubMed ID: 16828725
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum tumor marker CYFRA 21-1 in the diagnostics of squamous cell lung cancer--comparison with CEA.
    Berzinec P; Zuffová H; Letkovicová M; Arpásová M
    Neoplasma; 1996; 43(3):159-61. PubMed ID: 8841502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
    Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y
    Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum tumor marker TPS (tissue polypeptide-specific antigen)].
    Sergeeva NS; Dubovetskaia OB; Marshutina NV; Rodina IA; Mishunina MP; Beliaeva IG; Nesterova OA; Sergeeva VS
    Vopr Onkol; 2004; 50(6):637-43. PubMed ID: 15755055
    [No Abstract]   [Full Text] [Related]  

  • 37. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
    Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
    Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The value of serum tumor-associated glycoprotein 72 (TAG 72) in the diagnosis of malignancies].
    Sun G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):447-50. PubMed ID: 1303818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].
    Hefler L; Tempfer C; Häusler G; Heinzl H; Kainz C
    Wien Klin Wochenschr; 1998 Oct; 110(18):635-41. PubMed ID: 9816636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.